Bone Marrow Transplantation

Top Story

FDA grants Jakafi breakthrough designation to treat acute GVHD

June 23, 2016

The FDA granted ruxolitinib breakthrough therapy designation for the treatment of patients with acute graft-versus-host disease.

No therapy is currently FDA–approved for acute GVHD.

Meeting News CoverageVideo

VIDEO: Merge of immunotherapy, genomics lead to personalized treatment

June 23, 2016
CHICAGO — Candace Johnson, PhD, president and CEO of Roswell Park Cancer Institute, discusses how research in immunotherapy and genomics can lead to tailored…
Meeting News CoverageVideo

VIDEO: Diabetes, obesity associated with chemotherapy-induced neuropathy

June 22, 2016
CHICAGO — Dawn L. Hershman, MD, MS, associate professor of medicine at Columbia University Medical Center, reviews study results that identified comorbidities and…

White Out Cancer Day increases awareness of cancer immunotherapy

June 17, 2016
Employees of SLACK Incorporated — publisher of HemOnc Today — wore white today in support of White Out Cancer Day. The Cancer Research Institute started the…
CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
Video
Meeting News Coverage

CD19-targeted T-cells show potential in B-ALL, allogeneic stem cell transplantation

June 19, 2014
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
FDA News

FDA grants Jakafi breakthrough designation to treat acute GVHD

June 23, 2016
The FDA granted ruxolitinib breakthrough therapy designation for the treatment of patients with acute graft-versus-host disease. No therapy is…

Meeting News CoverageVideo

VIDEO: Merge of immunotherapy, genomics lead to personalized treatment

June 23, 2016
CHICAGO — Candace Johnson, PhD, president and CEO of Roswell Park Cancer Institute, discusses how research in immunotherapy and genomics can…

Meeting News CoverageVideo

VIDEO: Diabetes, obesity associated with chemotherapy-induced neuropathy

June 22, 2016
CHICAGO — Dawn L. Hershman, MD, MS, associate professor of medicine at Columbia University Medical Center, reviews study results that…

White Out Cancer Day increases awareness of cancer immunotherapy

June 17, 2016
Employees of SLACK Incorporated — publisher of HemOnc Today — wore white today in support of White Out Cancer Day. The Cancer Research…

In the Journals

Coffee no longer classified as a carcinogen

June 15, 2016
Coffee no longer should be classified as carcinogenic to humans, according to a working group from WHO’s International Agency for Research on…

Seven important updates from the ASCO Annual Meeting

June 10, 2016
This year’s ASCO Annual Meeting featured the theme “Collective wisdom: The future of patient-centered care and research.” HemOnc

Meeting News Coverage

Longer anticoagulation therapy may reduce VTE recurrence in patients with cancer

June 8, 2016
CHICAGO — Extending anticoagulation beyond 3 months reduced risk for recurrent clots in patients with cancer, according to results presented at…

Meeting News Coverage

Global variation in cancer drug prices does not reflect affordability

June 7, 2016
CHICAGO — Despite global variance in cancer drug prices, generic and patented drugs are less affordable in low-income countries, according to a…

Meeting News CoveragePerspective

Liquid biopsy assay exhibits efficacy similar to traditional tumor biopsy

June 4, 2016
CHICAGO — Liquid biopsy identified genomic alterations in patients with advanced solid tumors at a similar rate to traditional tumor biopsy…

In the Journals

Certain broad-spectrum antibiotics linked to mortality in stem cell transplant recipients

June 3, 2016
The use of broad-spectrum antibiotics, particularly piperacillin-tazobactam and Primaxin, for the treatment of neutropenic fever in allogeneic…

More Headlines »
morganatic-roan